TARS logo

Tarsus Pharmaceuticals, Inc. (TARS) Net Income

Annual Net Income:

-$115.55M+$20.34M(+14.97%)
December 31, 2024

Summary

  • As of today, TARS annual net profit is -$115.55 million, with the most recent change of +$20.34 million (+14.97%) on December 31, 2024.
  • During the last 3 years, TARS annual net income has fallen by -$101.73 million (-735.71%).
  • TARS annual net income is now -8660.73% below its all-time high of -$1.32 million, reached on December 31, 2018.

Performance

TARS Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Quarterly Net Income:

-$12.59M+$7.75M(+38.13%)
September 30, 2025

Summary

  • As of today, TARS quarterly net profit is -$12.59 million, with the most recent change of +$7.75 million (+38.13%) on September 30, 2025.
  • Over the past year, TARS quarterly net income has increased by +$10.84 million (+46.26%).
  • TARS quarterly net income is now -222.35% below its all-time high of $10.29 million, reached on March 31, 2021.

Performance

TARS Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

TTM Net Income:

-$81.16M+$10.84M(+11.78%)
September 30, 2025

Summary

  • As of today, TARS TTM net profit is -$81.16 million, with the most recent change of +$10.84 million (+11.78%) on September 30, 2025.
  • Over the past year, TARS TTM net income has increased by +$53.19 million (+39.59%).
  • TARS TTM net income is now -11817.47% below its all-time high of -$681.00 thousand, reached on September 30, 2019.

Performance

TARS TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TARS Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+15.0%+46.3%+39.6%
3Y3 Years-735.7%+44.1%-28.1%
5Y5 Years-2374.4%-24.1%-571.0%

TARS Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-735.7%+15.0%at high+70.0%-30.7%+45.9%
5Y5-Year-2374.4%+15.0%-222.3%+70.0%-1516.7%+45.9%
All-TimeAll-Time-8660.7%+15.0%-222.3%+70.0%>-9999.0%+45.9%

TARS Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$12.59M(+38.1%)
-$81.16M(+11.8%)
Jun 2025
-
-$20.34M(+19.0%)
-$91.99M(+12.3%)
Mar 2025
-
-$25.12M(-8.7%)
-$104.94M(+9.2%)
Dec 2024
-$115.55M(+15.0%)
-$23.11M(+1.3%)
-$115.55M(+14.0%)
Sep 2024
-
-$23.42M(+29.6%)
-$134.34M(+10.5%)
Jun 2024
-
-$33.29M(+6.8%)
-$150.07M(-1.3%)
Mar 2024
-
-$35.73M(+14.7%)
-$148.21M(-9.1%)
Dec 2023
-$135.89M(-118.9%)
-$41.90M(-7.0%)
-$135.89M(-26.3%)
Sep 2023
-
-$39.15M(-24.6%)
-$107.59M(-18.3%)
Jun 2023
-
-$31.42M(-34.2%)
-$90.95M(-39.3%)
Mar 2023
-
-$23.42M(-72.2%)
-$65.27M(-5.1%)
Dec 2022
-$62.09M
-$13.60M(+39.6%)
-$62.09M(+2.0%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$22.51M(-292.0%)
-$63.34M(-12.1%)
Jun 2022
-
-$5.74M(+71.6%)
-$56.53M(-27.1%)
Mar 2022
-
-$20.24M(-36.3%)
-$44.49M(-218.6%)
Dec 2021
-$13.83M(+48.4%)
-$14.85M(+5.4%)
-$13.96M(-32.0%)
Sep 2021
-
-$15.70M(-349.2%)
-$10.58M(-110.7%)
Jun 2021
-
$6.30M(-38.8%)
-$5.02M(+55.6%)
Mar 2021
-
$10.29M(+189.7%)
-$11.32M(+52.0%)
Dec 2020
-$26.81M(-474.1%)
-$11.47M(-13.1%)
-$23.56M(-94.8%)
Sep 2020
-
-$10.14M(-418.0%)
-$12.10M(-358.5%)
Mar 2020
-
-$1.96M(-187.4%)
-$2.64M(-287.4%)
Dec 2019
-$4.67M(-254.1%)
-
-
Sep 2019
-
-$681.00K
-$681.00K
Dec 2018
-$1.32M
-
-

FAQ

  • What is Tarsus Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Tarsus Pharmaceuticals, Inc. annual net profit?

The current annual net income of TARS is -$115.55M

What is the all-time high annual net income for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high annual net profit is -$1.32M

What is Tarsus Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, TARS annual net profit has changed by +$20.34M (+14.97%)

What is Tarsus Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of TARS is -$12.59M

What is the all-time high quarterly net income for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high quarterly net profit is $10.29M

What is Tarsus Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, TARS quarterly net profit has changed by +$10.84M (+46.26%)

What is Tarsus Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of TARS is -$81.16M

What is the all-time high TTM net income for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high TTM net profit is -$681.00K

What is Tarsus Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, TARS TTM net profit has changed by +$53.19M (+39.59%)
On this page